Please assess the completion status of the following clinical trial:

Trial Title: Minirin Versus Oxybutynin for Nocturnal Enuresis in Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* \>5 years old~* Nocturnal enuresis~* Candidate for pharmacological treatment~Exclusion Criteria:~* Children who their parents did noted filled the informed consent form~* Impossibility of follow up during the study period~* History of seizure~* History of rheumatologic disorders such as sjogren's disease

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- Minirin (Type: EXPERIMENTAL): 120 microgram per day for 2 months, then 60 microgram per day for 2 months, then 60 microgram every two days for two months
- Oxybutynin (Type: ACTIVE_COMPARATOR): 5 mg Oxybutynin twice a daily for 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).